CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately Predict Voriconazole Clearance in Healthy Adults.
Amin MuharebAntje BlankAndreas Daniel MeidKathrin I FoersterFelicitas StollJuergen BurhenneWalter Emil HaefeliGerd MikusPublished in: Clinical pharmacokinetics (2023)
TRIAL REGISTRATION: EudraCT No: 2020-001017-20, registered on March 5th, 2020. DRKS: DRKS00022547, registered on August 6th, 2020.